Alzamend Neuro (ALZN) Stock Price, News & Analysis

Alzamend Neuro's stock was trading at $0.89 at the beginning of the year. Since then, ALZN stock has decreased by 24.1% and is now trading at $0.6755.
View the best growth stocks for 2024 here.

Alzamend Neuro saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 45,300 shares, a drop of 11.5% from the March 15th total of 51,200 shares. Based on an average daily volume of 54,600 shares, the days-to-cover ratio is presently 0.8 days. Approximately 0.9% of the shares of the company are sold short.
View Alzamend Neuro's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 25th 2024.
View our ALZN earnings forecast.

Alzamend Neuro, Inc. (NASDAQ:ALZN) issued its earnings results on Monday, March, 25th. The company reported ($0.38) EPS for the quarter.

Alzamend Neuro shares reverse split on the morning of Tuesday, October 31st 2023. The 1-15 reverse split was announced on Tuesday, October 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, October 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Alzamend Neuro (ALZN) raised $12 million in an initial public offering (IPO) on Tuesday, June 15th 2021. The company issued 2,500,000 shares at $5.00 per share. Spartan Capital Securities, LLC served as the underwriter for the IPO and -- was co-manager.

Shares of ALZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.